Author:
Hughes Cian,Sreenilayam Sithara,Brabazon Dermot
Abstract
AbstractThe advancement of biosensor research has been a primary driving force in the continuing progress of modern medical science. While traditional nanofabrication methods have long been the foundation of biosensor research, recent years have seen a shift in the field of nanofabrication towards laser-based techniques. Here we report a gold-based biosensor, with a limit of detection (LoD) 3.18 µM, developed using environmentally friendly Laser Ablation Synthesis in Liquid (LASiS) and Confined Atmospheric Pulsed-laser (CAP) deposition techniques for the first time. The sensors were able detect a DNA fragment corresponding to the longest unpaired sequence of the c-Myc gene, indicating their potential for detecting such fragments in the ctDNA signature of various cancers. The LoD of the developed novel biosensor highlights its reliability and sensitivity as an analytical platform. The reproducibility of the sensor was examined via the production and testing of 200 sensors with the same fabrication methodology. This work offers a scalable, and green approach to fabricating viable biosensors capable of detecting clinically relevant oncogenic targets.
Funder
Science Foundation Ireland
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Piunno, P. A. E. & Krull, U. J. Trends in the development of nucleic acid biosensors for medical diagnostics. Anal. Bioanal. Chem. 381, 1004–1011 (2005).
2. Bekmurzayeva, A. et al. Ultra-wide, attomolar-level limit detection of CD44 biomarker with a silanized optical fiber biosensor. Biosens. Bioelectron. 208, 114217 (2022).
3. Ruan, C. & Li, Y. Detection of zeptomolar concentrations of alkaline phosphatase based on a tyrosinase and Horse-Radish peroxidase bienzyme biosensor. Talanta 54, 1095–1103 (2001).
4. El-Sherif, D. M. et al. New approach in SARS-CoV-2 surveillance using biosensor technology: A review. Environ. Sci. Pollut. Res. 29, 1677–1695 (2022).
5. Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries. https://www.who.int/news/item/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countries. (accessed 2023–03–30).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献